To include your compound in the COVID-19 Resource Center, submit it here.

FDA completes review of GENZ's Fabrazyme

Genzyme (GENZ) said the FDA completed its review of GENZ's BLA for Fabrazyme agalsidase beta enzyme

Read the full 162 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE